- Filed
- May 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 12, 2025 | 340.39M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $368.79K |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $322.43K |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $4.61M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $4.82M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $9.88M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $10.08M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $701.81K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $651.4K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.41M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.04M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 148.15M sh |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | $111.1K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | −$5.26M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$5.31M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $70.7K |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $40.51K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $53.65K |
| Gross Profit restated | Q1 2025 · Mar 31, 2024 | $124.35K |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $144.86K |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $269.21K |